ArticleScientific reports2026

Dihydroartemisinin exerts antitumour activity by blocking SIRT2-IGFBP1-induced PI3K/AKT/mTOR signal transduction in liver cancer.

Zhengbin Chai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.